RxDoctor Payments DataLook up a doctor →

Brook Brouha, MD

Dermatopathology · la Jolla, CANPI 1114173937

Payments from drug & device makers

$20,064in general payments, 2019–2025

Across 911 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$3K
  • AbbVie$2K
  • Johnson & Johnson$2K
  • Pfizer$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Incyte Corporation$1K
  • plus $9K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arcutis Biotherapeutics, Inc.23$2,666
AbbVie132$2,385
Johnson & Johnson69$1,529
Pfizer85$1,461
Sun Pharmaceutical Industries Inc.67$1,336
Incyte Corporation59$1,231
Lilly USA, LLC75$1,173
Regeneron Healthcare Solutions, Inc.46$1,161
Sanofi36$989
LEO Pharma Inc.77$937
Novartis38$741
Galderma Laboratories, L.p.30$634
UCB, Inc.37$630
Amgen23$538
Biofrontera Inc.11$301
Almirall LLC16$253
Sanofi-aventis U.S. LLC12$235
Dermira, Inc.8$206
Hill Dermaceuticals, Inc.1$204
Dermavant Sciences, Inc.8$159
Boehringer Ingelheim6$147
Genentech USA, Inc.6$124
Strata Skin Sciences, Inc.5$106
E.r. Squibb & Sons, L.L.C.4$102
Tactile Systems Technology Inc7$98
Ortho Dermatologics, A Division Of Bausch Health US, LLC5$90
Stemline Therapeutics Inc.1$82
Bristol Myers Squibb3$79
Koya Medical, Inc.2$65
Merck3$57
Helsinn Therapeutics (U.S.), Inc.3$50
Botanix SB Inc2$49
Kyowa Kirin, Inc.2$46
Merz North America, Inc.1$45
Journey Medical Corporation2$39
VYNE Pharmaceuticals Inc.2$37
Verrica Pharmaceuticals Inc.2$35
Organon1$26
DUSA Pharmaceuticals, Inc.1$22

How this compares

$20,064 in reported general payments places this provider in the 95th percentile of 76 dermatopathology providers in California.

See all dermatopathology providers in California →

Medicare billing

Part B allowed, 2024
$398,799
Medicare patients
967
Services billed
15,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in la Jolla

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →